Evidence of increased radiation resistance in brain CSCs has come mainly from studies of glioma and atypical teratoid/rhabdoid tumors (AT/RT) for which experimental isolation depended on CD133 [19-23]. This evidence concerns the gene PROM1 and central nervous system cancer.